US20070009692A1 - High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions - Google Patents

High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions Download PDF

Info

Publication number
US20070009692A1
US20070009692A1 US11/475,745 US47574506A US2007009692A1 US 20070009692 A1 US20070009692 A1 US 20070009692A1 US 47574506 A US47574506 A US 47574506A US 2007009692 A1 US2007009692 A1 US 2007009692A1
Authority
US
United States
Prior art keywords
balloon
diameter
atmospheres
pressure
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/475,745
Inventor
Lixiao Wang
Donald Fournier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Corp
Original Assignee
Boston Scientific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/397,837 external-priority patent/US5556383A/en
Application filed by Boston Scientific Corp filed Critical Boston Scientific Corp
Priority to US11/475,745 priority Critical patent/US20070009692A1/en
Publication of US20070009692A1 publication Critical patent/US20070009692A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1027Making of balloon catheters
    • A61M25/1029Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/04Macromolecular materials
    • A61L29/06Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1027Making of balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1088Balloon catheters with special features or adapted for special applications having special surface characteristics depending on material properties or added substances, e.g. for reducing friction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S264/00Plastic and nonmetallic article shaping or treating: processes
    • Y10S264/90Direct application of fluid pressure differential to shape, reshape, i.e. distort, or sustain an article or preform and heat-setting, i.e. crystallizing of stretched or molecularly oriented portion thereof
    • Y10S264/903Heat-setting and simultaneous differential heating of stretched or molecularly oriented section of article or preform
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S264/00Plastic and nonmetallic article shaping or treating: processes
    • Y10S264/90Direct application of fluid pressure differential to shape, reshape, i.e. distort, or sustain an article or preform and heat-setting, i.e. crystallizing of stretched or molecularly oriented portion thereof
    • Y10S264/905Direct application of fluid pressure differential to shape, reshape, i.e. distort, or sustain an article or preform and heat-setting, i.e. crystallizing of stretched or molecularly oriented portion thereof having plural, distinct differential fluid pressure shaping steps
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S264/00Plastic and nonmetallic article shaping or treating: processes
    • Y10S264/90Direct application of fluid pressure differential to shape, reshape, i.e. distort, or sustain an article or preform and heat-setting, i.e. crystallizing of stretched or molecularly oriented portion thereof
    • Y10S264/905Direct application of fluid pressure differential to shape, reshape, i.e. distort, or sustain an article or preform and heat-setting, i.e. crystallizing of stretched or molecularly oriented portion thereof having plural, distinct differential fluid pressure shaping steps
    • Y10S264/906And heat-shrinking outside of mold including subsequent re-expanding of shrunken article using differential fluid pressure
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1334Nonself-supporting tubular film or bag [e.g., pouch, envelope, packet, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352Polymer or resin containing [i.e., natural or synthetic]

Definitions

  • Balloons mounted on the distal ends of catheters are widely used in medical treatment.
  • the balloon may be used to widen a vessel into which the catheter is inserted or to force open a blocked vessel.
  • the requirements for strength and size of the balloons vary widely depending on the balloon's intended use and the vessel size into which the catheter is inserted.
  • the balloon must have some elasticity so that the inflated diameter can be controlled, enabling the surgeon to vary the balloon's diameter as required to treat individual lesions, but that elasticity must be relatively low so that the diameter is easily controllable. Small variations in pressure must not cause wide variation in diameter.
  • Such angioplasty balloons have nominal diameters in the range of from about 1.25-4.5 mm.
  • balloon dilatation is the most recently developed modality.
  • Clinical research studies have been conducted to compare the efficacy of the technique to earlier approaches. For example, in one study evaluating Savary-Guillard® Dilators versus balloon dilators for dilatation of benign esophageal strictures, both methods achieved effective dilatation. However, during the 24 month follow-up, 88% of patients treated with Savary dilators required redilations vs 54% of patients in the balloon group. As a result, the researchers concluded that, over the long term, the balloon may provide superior efficacy. Additional studies have clearly documented the convenience, effectiveness and safety of balloon dilatation of strictures.
  • An example is the treatment of esophagal achalasia.
  • the esophagus a hollow, muscular organ that originates at the pharynx and terminates at the stomach, functions to transport food and fluids from the pharynx to the stomach via a complex, neuromuscular response to the act of swallowing. Specifically, the passage of food or fluid from the pharynx into the esophagus stimulates the peristaltic contractions designed to propel the contents forward through the esophagus. Concurrently, the lower esophageal sphincter (LES) at the gastroesophagal junction relaxes allowing the passage of esophagal contents into the stomach.
  • LES lower esophageal sphincter
  • Achalasia is a disorder of unknown etiology that disrupts the normal esophageal function ( 3 , 4 ). In this disorder, two deficits are present. First, the normal esophagal peristaltic wave is absent. Second, the lower esophageal sphincter does not relax. The result is esophageal dilatation and severe, progressive dysphagia. Treatment for achalasia is aimed at reduction of LES pressure. This is accomplished nonsurgically via forceful balloon dilatation of the sphincter.
  • Biliary dilatation may also be performed by such balloon catheter dilatation. Biliary strictures may result from variety of processes including postoperative scarring, inflammation, or malignancy. Endoscopic balloon dilatation of these lesions has been shown to be an effective treatment approach.
  • the balloons for such devices desirably would have a long dilation length, high operating pressure, typically greater than 50 psi (3 atm, 344.7 kPa) and desirably up to 146 psi, (10 atm, 1013 kPa), low withdrawal force and high compliance.
  • a compliance change is desirable which would allow a balloon having a 1.25-3.0 mm nominal diameter at 3 atm to grow in a generally linear manner at least 0.25 mm, preferably about 0.5 mm, or more as pressure is increased from 3 to 12 atm.
  • a growth of at least 1.0 mm over the same range would be desirable.
  • a growth of at least 2.0 mm over a 3-10 atm pressure range would be desirable.
  • a compliance curve which provides growth of about 3 mm or more, preferably about 4.0 mm or more, over the range of 3 to 9 atm is desirable.
  • a single layer angioplasty balloon made of a material such as PET which follows a stepped compliance curve.
  • the stepped compliance curves of these balloons have a low pressure segment following a first generally linear profile, a transition region, typically in the 8-14 atm range, during which the balloon rapidly expands yielding inelastically, and a higher pressure region in which the balloon expands along a generally linear, low compliance curve.
  • the stepped compliance curve allows a physician to dilate different sized lesions without using multiple balloon catheters.
  • a polyethylene ionomer balloon with a stepped compliance curve is disclosed in EP 540 858.
  • Block copolymer balloons for balloon catheters prepared using a particular heat set technique to stabilize the balloon dimensions, are also described in U.S. Pat. No. 5,500,180.
  • the invention provides balloons having the desired properties just described.
  • the invention is a method for forming a balloon for a medical device in which a tubing of a thermoplastic polymer material is radially expanded under a first elevated pressure at a first elevated temperature to form the balloon at a first diameter, the thermoplastic polymer material being a block copolymer material and the method including the further step of annealing the balloon at a second elevated temperature less than or equal to the first temperature and a second pressure less than the first elevated pressure for a time sufficient to shrink the formed balloon to a second diameter less than the first diameter.
  • the second temperature is in the range of 70-100° C.
  • the second pressure is no more than about 50 psi
  • the time of annealing is sufficient to shrink the balloon so that its diameter at 3 atm pressure is about 90% or less, preferably about 85% or less, of the 3 atm diameter of a correspondingly prepared balloon prepared without said shrinking step.
  • the balloon may be shrunk at a very low inflation pressure (typically 0-10 psi) to a nominal diameter below that desired in the final balloon, and then pressurized at a pressure between the shrink pressure and 50 psi, at a temperature within the same range within a mold or cylinder which is sized to provide the desired nominal diameter, still below the diameter at which the balloon was initially blown, and suitably 90% or less of the initial blow diameter.
  • a very low inflation pressure typically 0-10 psi
  • the shrinking process used in the invention is quite different from the heat set technique used in U.S. Pat. No. 5,500,180, in that the process of U.S. Pat. No. 5,500,180, after formation of the balloon heats the balloon under pressure of 100-500 psi to a temperature above the blowing temperature specifically for the purpose of stabilizing the balloon against shrinkage upon cooling.
  • the present invention is directed to exploitation of shrinkage behavior in order to increase the compliance of the resulting balloon.
  • Balloons made of multiple layers of thermoplastic material such as coextruded balloons of the types described in U.S. Pat. No. 5,195,969, U.S. Pat. No. 5,270,086, and U.S. Pat. No. 5,478,320, or separately blown dual layer balloons of the types described in U.S. Pat. No. 5,512,051, WO 96/04951 and in copending application Ser. No. 08/611,644, filed 6 Mar. 1996, all incorporated herein by reference, may also be employed in the present invention by shrinking the so-formed balloon in accordance with the present invention after it has been formed.
  • balloons particularly suited to dilation of GI lesions of various types which are characterized by unique combinations of balloon diameter, high burst strength and high compliance characteristics.
  • the high strength, high compliance balloons of the invention also provide excellent rewrap characteristics, in comparison to high strength balloons formed by other processes. Consequently, after treatment of a lesion and deflation of the balloon, the force required to withdraw the balloon catheter from the body is low, especially for catheters designed to pass through endoscopes (TTS).
  • TTS endoscopes
  • FIG. 1 is a schematic side view of a through-the scope dilatation catheter of the invention.
  • FIG. 2 is a schematic side view of a dual lumen over-the wire dilatation catheter of the invention.
  • FIG. 3 is a plot showing compliance curves of balloons prepared in Examples 3 and 4.
  • FIG. 4 is a plot showing compliance curves of balloons prepared in Example 5.
  • FIG. 5 is a plot showing compliance curves of balloons prepared in Example 6.
  • balloon dilatation catheters for gastrointestinal applications are available in two design options: 1) through-the scope (TTS); and 2) over-the-wire (OTW).
  • TTS through-the scope
  • OGW over-the-wire
  • a TTS balloon dilatation catheter 10 comprises a shaft 12 , a balloon 14 near the distal end thereof and an inflation apparatus 16 at the proximal end thereof.
  • Shaft 12 has a strong flexible kink-resistant construction and includes a longitudinal lumen extending therethrough by means of which the balloon 14 may be inflated by the inflation apparatus 16 .
  • Catheter 10 is designed for direct passage through the working channel of the endoscope to the site of an obstructive lesion. Because TTS catheters are not passed over a guidewire, the design includes a mechanism for stiffening the shaft enough to allow advancement through the narrow scope channel to the lesion.
  • TTS catheters suitably incorporate a stiffening stylet 18 within the shaft.
  • This stylet extends from the proximal end of the shaft through the length of the balloon and provides the stiffness required to facilitate passage through an endoscope and enhance appropriate positioning within the lesion.
  • TTS balloon dilatation catheters are useful when an endoscopist prefers to dilate under direct visualization.
  • catheter advancement and balloon inflation can be directly monitored.
  • Scope placement immediately proximal to the balloon also assists in maintaining proper balloon position during inflation. For example, during dilatation of pyloric structures, the balloon has a tendency to slip proximally or distally during inflation.
  • the endoscopist is able to mechanically block any backward movement during inflation thereby facilitating efficient, effective dilatation.
  • FIG. 2 illustrates the construction of an OTW balloon dilation catheter 30 .
  • Catheter 30 includes a shaft 32 which has a strong flexible kink-resistant construction and incorporates a double-lumen design. This design provides a lumen for guidewire passage and a lumen for balloon inflation. At the proximal end of catheter 30 the lumens of shaft 32 divide into separate portions 34 , 36 which communicate respectively to balloon inflation apparatus 38 and to guidewire control apparatus 40 .
  • a balloon 42 is mounted on the shaft 32 near the distal end of catheter 30 .
  • Catheter 30 may incorporate a soft flexible tip 44 to provide less traumatic advancement through tortuous or narrow strictures. Tip 44 may be radiopaque to assist in fluoroscopic positioning of the catheter at the lesion site.
  • OTW balloon dilatation catheters are the preferred design option when extremely tortuous of difficult anatomy is encountered. In these cases, the ability to track the catheter over a previously placed guidewire enhances the clinician's ability to precisely position the balloon for effective dilatation. Further, for colonic lesions distal to scope access, a fluoroscopically-guided, OTW placement technique can be used to achieve appropriate positioning.
  • OTW balloon dilatation catheters With OTW balloon dilatation catheters, the endoscopist typically monitors balloon inflation fluoroscopically rather than under direct visualization. Therefore, these dilators incorporate radiopaque markers to aid in accurate positioning. These catheters are designed to be used with guidewires and are available in a variety of shaft and balloon lengths and diameters. This allows the endoscopist to select a catheter appropriate for each lesion.
  • the balloon must provide effective radial force against the entire length of the stricture.
  • the balloon diameter is indicated by dimension A and the dilation length indicated by dimension B.
  • the balloon should be long enough to dilate the entire length of the stricture.
  • the inflated outer diameter should affect the desired degree of dilatation.
  • the length of the catheter shaft required varies with the location of the stricture. For example, catheters 180 cm in length allow access to esophageal and pyloric lesions, while a catheter 240 cm in length is required for colonic strictures.
  • Balloon Dilators which are inflated with air
  • balloons are primarily inflated with water, saline or a contract/saline mixture.
  • the latter is used with OTW balloon catheters to enhance visualization. It is important not to exceed the maximum inflation pressure specified for any particular balloon catheter. Surpassing this pressure could lead to balloon rupture.
  • the balloon is fully inflated to the desired dilatation diameter. Dilatation force is applied for as long as necessary to achieve desired results.
  • the balloons of the present invention provide a substantially wider range of stricture diameters which may be treated with a single catheter. After treatment, the deflated balloons of the invention provide substantially reduced resistance to withdrawal of the catheter from the body compared to prior art high strength balloons made for instance from biaxially oriented PET. In some TTS applications measured withdrawal force through the scope for catheters bearing balloons of the invention has been found to be only about 1 ⁇ 2 of the withdrawal force for corresponding catheters bearing PET balloons of similar burst strength.
  • a balloon of approximately 8 cm length (dimension B), having an outer diameter (dimension A) of 6 to 20 mm is suitable.
  • the preferred length of the catheter is 180 cm.
  • a balloon of approximately 5.5 cm length balloon, having an outer diameter of 6 to 20 mm is suitable.
  • the preferred length of the catheter is 180 cm.
  • a balloon of approximately 5.5 cm length balloon, having an outer diameter of 6 to 20 mm is suitable.
  • the preferred length of the catheter is 240 cm.
  • a balloon of approximately 8 cm length balloon, having an outer diameter of 20-30 mm is suitable.
  • the preferred length of the catheter is 240 cm.
  • Preferred balloon materials are block copolymers or blends of flexible and rigid thermoplastic polymers. Particularily preferred are thermoplastic block copolymers characterized as follows:
  • the block copolymer is made up of hard segments of a polyester or polyamide and soft segments of polyether;
  • the percentage by weight of the block polymer attributable to the hard segments is between about 50% and about 98%.
  • the block copolymer has a low flexural modulus, namely less than 150,000 psi, preferably less than 120,000 psi, and has a hardness, Shore D scale, of greater than 60. From such polymers, balloons having very high compliance profiles can be prepared with high wall strength. The low flexural modulus contributes to a softer feel found with the balloons of the invention, compared to those made of other high strength polymer material.
  • the preferred balloons of the invention are made of polyamide/polyether block copolymers.
  • the polyamide/polyether block copolymers are commonly identified by the acronym PEBA (polyether block amide).
  • PEBA polyether block amide
  • the polyamide and polyether segments of these block copolymers may be linked through amide linkages, however, most preferred are ester linked segmented polymers, i.e. polyamide/polyether polyesters.
  • Such polyamide/polyether/polyester block copolymers are made by a molten state polycondensation reaction of a dicarboxylic polyamide and a polyether diol. The result is a short chain polyester made up of blocks of polyamide and polyether.
  • the polyamide and polyether blocks are not miscible.
  • the materials are characterized by a two phase structure: one is a thermoplastic region that is primarily polyamide and the other is elastomer region that is rich in polyether.
  • the polyamide segments are semicrystalline at room temperature.
  • the generalized chemical formula for these polyester polymers may be represented by the following formula: in which PA is a polyamide segment, PE is a polyether segment and the repeating number n is between 5 and 10.
  • the polyamide segments are suitably aliphatic polyamides, such as nylons 12, 11, 9, 6, 6/12, 6/11, 6/9, or 6/6. Most preferably they are nylon 12 segments.
  • the polyamide segments may also be based on aromatic polyamides but in such case significantly lower compliance characteristics are to be expected.
  • the polyamide segments are relatively low molecular weight, generally within the range of 500-8,000, more preferably 2,000, most preferably about 3,000.
  • the polyether segments are aliphatic polyethers having at least 2 and no more than 10 linear saturated aliphatic carbon atoms between ether linkages. More preferably the ether segments have 4-6 carbons between ether linkages, and most preferably they are poly(tetramethylene ether) segments. Examples of other polyethers which may be employed in place of the preferred tetramethylene ether segments include polyethylene glycol, polypropylene glycol, poly(pentamethylene ether) and poly(hexamethylene ether). The hydrocarbon portions of the polyether may be optionally branched. An example is the polyether of 2-ethylhexane diol. Generally such branches will contain no more than two carbon atoms. The molecular weight of the polyether segments is suitably between about 400 and 2,500, preferably between 650 and 1000.
  • the weight ratio of polyamide to polyether in the polyamide/polyether polyesters used in the invention desirably should be in the range of 50/50 to 98/2, preferably between 60/30 and 92/08, more preferably, between 70/30 and 90/10.
  • Polyamide/polyether polyesters are sold commercially under the Pebax® trademark by Atochem North America, Inc., Philadelphia Pa.
  • suitable commercially available polymers are the Pebax® 33 series polymers with hardness 60 and above, Shore D scale, especially Pebax® 7233, 7033 and 6333. These polymers are made up of nylon 12 segments and poly(tetramethylene ether) segments in different weight ratios and segment lengths.
  • polyester/polyether segmented block copolymers As an alternative to polyamide elastomers, it is also possible to utilize polyester/polyether segmented block copolymers and obtain similar balloon properties.
  • Such polymers are made up of at least two polyester and at least two polyether segments.
  • the polyether segments are the same as previously described for the polyamide/polyether block copolymers useful in the invention.
  • the polyester segments are polyesters of an aromatic dicarboxylic acid and a two to four carbon diol.
  • Suitable dicarboxylic acids used to prepare the polyester segments of the polyester/polyether block copolymers are ortho-, meta- or para-phthalic acid, napthalenedicarboxylic acid or meta-terphenyl-4,4′-dicarboxylic acids.
  • polyester/polyether block copolymers are poly(butylene terephthalate)-block-poly(tetramethylene oxide) polymers such as Arnitel EM 740, sold by DSM Engineering Plastics. Hytrel polymers, sold by DuPont which meet the physical and chemical specifications set out herein can also be used.
  • thermoplastic polymer materials which may be used to prepare balloons in accordance with the invention include blends of rigid and flexible polymers; polyurethanes which have flexible portions, typically derived from polyester or polyether polyols and rigid portions, typically derived from diisocyanates; random copolymers of rigid and flexible monomers; aliphatic polyketones; polysulfides such as PPS (polyphenylenesulfide); polyamides, for instance C 6 or higher polyamides which are saturated with water, C 11 or higher polyamide homopolymers regardless of water content, and polyamide copolymers of linear and branched monomer units; and other polymers or polymer blends which are known in the art as thermoplastic elastomers.
  • thermoplastic polymer products which are considered suitable include polyurethane/polycarbonate blend or block copolymers sold under the trademarks, TEXIN TPU by Bayer Corp and TECOTHANE by Thermedics Inc. and polyurethanes sold under the trademark PELLETHANE by Dow Chemical Co.
  • polyurethane/polycarbonate blend or block copolymers sold under the trademarks, TEXIN TPU by Bayer Corp and TECOTHANE by Thermedics Inc. and polyurethanes sold under the trademark PELLETHANE by Dow Chemical Co.
  • multilayer balloon structures formed by concentric coextrusion of different thermoplastic polymers, or by sequential concentric blowing of separate tubing parisons of different materials may also be employed.
  • Manufacture of balloons of the invention is started with an extruded tubing of the thermoplastic polymer material.
  • the balloon prior to its being shrunk, may be manufactured in accordance with known techniques such as described in copending application Ser. No. 08/397,837, filed 2 Mar. 1995, entitled Block Copolymer Elastomer Catheter Balloons, incorporated herein by reference, which corresponds to WO 95/23619, and Ser. No. 08/555,219, filed 8 Nov. 1995, entitled Method of Balloon Formation by Cold Drawing/Necking, incorporated herein by reference. Multi-staged blowing techniques as described in copending application Ser. No. 08/197,639, filed 17 Feb. 1994, also incorporated herein by reference, may also be employed.
  • the balloon shrinking process is similar to that described in U.S. Pat. No. 5,348,538 for balloons of non-compliant material such as PET.
  • the balloons of the invention are desirably constructed by blowing the balloon from a block copolymer or other polymer material as described above and then shrinking the balloon to a greater extent than was done in the specific illustrative examples of U.S. Pat. No. 5,348,538.
  • the amount of shrinkage is controlled by the pressure maintained in the balloon during annealing and the temperature and time of the annealing.
  • the blowing pressure is suitably in the range 200-400 psi, and temperature is suitably in the range of 90-100° C., and the annealing pressure is in the range of 0-50, preferably 1-30 psi at 70-100° C. for 3-30 seconds.
  • the balloon may be shrunk at a very low inflation pressure (typically 0-30 psi) to a nominal diameter below that desired in the final balloon, and then pressurized at a pressure between the shrink pressure and 50 psi, at a temperature within the same range within a mold or cylinder which is sized to provide the desired nominal diameter, still below the diameter at which the balloon was initially blown, and suitably 90% or less of the initial blow diameter.
  • a very low inflation pressure typically 0-30 psi
  • Example 10 is illustrative of this technique.
  • Pebax® 7233 tubes with dimensions of 0.105 inch ID (inner diameter) ⁇ 0.140 OD (outer diameter) are cold-drawn at a very low temperature, approximately in the range of ⁇ 100° C. to ⁇ 20° C. as follows.
  • a screw driven stretching machine with a pair of pneumatic grippers is used to stretch the tubing.
  • the center portion of the tube is cooled by directly spraying liquid N 2 on the center portion.
  • Five 50 mm length balloons are blown at 95° C. in a 16 mm diameter mold using a blowing pressure of 260 psi and a tension of 160 grams.
  • the average double wall thickness of the balloons was 0.00282 inch.
  • the burst pressure was 9.2 atm.
  • the compliance from 3 atm to 5 atm was 4.2% and from 3 atm to burst pressure was 11.7%.
  • Example 1 Five balloons were prepared as in Example 1. The balloons, while inflated at about 5 psi pressure, were shrunk by dipping in a 80° C. water bath for 5 minutes. The average double wall thickness after shrinking was 0.00429 inch. The average burst pressure of the balloons was 9.4 atm. The compliance from 3 atm to 5 atm was 15% and from 3 atm to burst pressure was 39%.
  • Pebax® 7233 tubes with dimensions of 0.0264 inch ID ⁇ 0.0464 OD (outer diameter) are cold-drawn as in Example 1.
  • a 4 mm balloon is blown at 95° C. in a mold using a blowing pressure of 450 psi and a tension of 300 grams.
  • the burst pressure was 22 atm.
  • Example 2 The process of Example 2 is repeated except that the shrinking step is performed by annealing the balloons while inflated to 2 atm pressure in water baths under different conditions, namely: 75° C. for 10 seconds; 75° C. for 30 seconds; 75° C. for 60 seconds; and 95° C. for 10 seconds. Compliance curves for the balloons of Examples 3 and 4 are plotted in FIG. 3 .
  • Balloons were prepared as in Examples 1 and 2 using Pebax 7033 polymer and the conditions specified in Table 1. The compliance results are summarized in Table 1 and are plotted in FIG. 4 .
  • Balloons were made from Amitel EM 740 polymer tubing by stretching tubing as specified in Table 2 at room temperature at a stretch ratio of 4.2 and then blowing the balloon from the stretched tubing under the conditions specified in Table 2.
  • the compliance results are summarized in Table 2 and are plotted in FIG. 5 .
  • TABLE 1 Mold Blowing Double Dia Length Tube ID ⁇ OD pressure Blowing wallshrinkingshrinking Burst pressure Compliance 3 Compliance Sample (mm) (mm) (inch) (atm) tension (g) thickness temp. ° C.
  • the balloons prepared utilizing the shrinking step have very high compliance profiles, in addition to high wall strength.
  • the shrinking step causes the compliance curve to start from a lower point so that overall the balloon is much more compliant. In this manner the comparatively high strength of the block copolymer material is made accessible to medical device applications where high compliance is also desirable.
  • Extruded Pebax 7233 tubes with dimensions of 0.0509 inch ID ⁇ 0.0729 inch OD were prepared.
  • Five 55 mm length balloons were blown at a temperature of 95° C. in an 8 mm diameter mold using a blowing pressure of 450 psi and a tension of 150 grams.
  • the average double wall thickness of the balloons was 0.00174 inch.
  • the average burst pressure was 13.6 atm.
  • the compliance from 3 atm to 10 atm was 9.0%, and from 3 atm to burst pressure was 15%.
  • Example 9 Five balloons were prepared as in Example 9. The balloons while at a tension and inflated at atmospheric pressure were shrunk by dipping in an 85° C. water bath for 2 minutes. The balloons were then each inserted into a 5.6 mm ID glass tube, replaced in the 85° bath and pressurized at 30 psi for 2 minutes. The resulting balloons had an average double wall thickness of 0.00233 inch, an average burst pressure of 12.6 mm, a compliance from 3 atm to 10 atm of 36% and a compliance from 3 atm to burst of 44%.

Abstract

Balloon especially useful for dilatation of gastrointestinal lesions have a burst pressure of at least 9 atmospheres, a diameter at 3 atmospheres of about 5 mm or more, and an average compliance over the range of from 3 atmospheres to burst of at least 3% per atmosphere. Such balloons and balloons having other combinations of burst strength, compliance and diameter may be prepared by a method wherein a tubing of a thermoplastic polymer material is radially expanded under a first elevated pressure at an elevated temperature to form the balloon at a first diameter and then annealing the balloon at a second elevated temperature and a second pressure less than the first elevated pressure for a time sufficient to shrink the formed balloon to a second diameter less than the first diameter. The thermoplastic polymer material may be a block copolymer material. Catheters bearing balloons prepared by this method have low withdrawal force requirements, especially catheters used in through-the-scope applications.

Description

    CROSS REFERENCE TO RELATED APPLICATION
  • This application is a continuation of U.S. application Ser. No. 11/009,355 filed Dec. 10, 2004, incorporated herein by reference in its entirety, allowed, which is a continuation of U.S. application Ser. No. 08/685,338, filed Jul. 23, 1996, which is a continuation-in-part of copending U.S. application Ser. No. 08/397,837, filed 2 Mar. 1995, now U.S. Pat. No. 5,556,383, which is a continuation-in-part of Ser. No. 08/204,554, filed Mar. 2, 1994, now abandoned.
  • BACKGROUND OF THE INVENTION
  • Balloons mounted on the distal ends of catheters are widely used in medical treatment. The balloon may be used to widen a vessel into which the catheter is inserted or to force open a blocked vessel. The requirements for strength and size of the balloons vary widely depending on the balloon's intended use and the vessel size into which the catheter is inserted.
  • Perhaps the most demanding applications for such balloons are in balloon angioplasty in which catheters are inserted for long distances into extremely small vessels and used to open stenoses of blood vessels by balloon inflation. These applications require extremely thin walled, high strength, relatively inelastic balloons of predictable inflation properties. Thin walls are necessary because the balloon's wall and waist thicknesses limit the minimum diameter of the distal end of the catheter and therefore determine the limits on vessel size treatable by the method and the ease of passage of the catheter through the vascular system. High strength is necessary because when the balloon is used to push open a stenosis, the thin wall must not burst under the high internal pressures necessary to accomplish this task. The balloon must have some elasticity so that the inflated diameter can be controlled, enabling the surgeon to vary the balloon's diameter as required to treat individual lesions, but that elasticity must be relatively low so that the diameter is easily controllable. Small variations in pressure must not cause wide variation in diameter. Such angioplasty balloons have nominal diameters in the range of from about 1.25-4.5 mm.
  • Outside the field of angioplasty, however, relatively high compliant, high strength materials are desirable for some balloons used on esophageal, pyloric, colonic and anastomotic catheters and scopes.
  • Major advances in the ability to access remote areas within the gastrointestinal tract have allowed endoscopists to reach obstructive lesions previously accessible only via open surgical techniques. There are three primary approaches available to the clinician for endoscopic treatment of gastrointestinal strictures: 1) Mercury bougie dilatation; 2) Over-the-wire passage of tapered dilators; and 3) Balloon dilation.
  • Of the three, balloon dilatation is the most recently developed modality. Clinical research studies have been conducted to compare the efficacy of the technique to earlier approaches. For example, in one study evaluating Savary-Guillard® Dilators versus balloon dilators for dilatation of benign esophageal strictures, both methods achieved effective dilatation. However, during the 24 month follow-up, 88% of patients treated with Savary dilators required redilations vs 54% of patients in the balloon group. As a result, the researchers concluded that, over the long term, the balloon may provide superior efficacy. Additional studies have clearly documented the convenience, effectiveness and safety of balloon dilatation of strictures.
  • An important advantage of balloon dilatation over the alternative techniques is that it enables the clinician to dilate remote strictures throughout the GI tract.
  • An example is the treatment of esophagal achalasia. The esophagus, a hollow, muscular organ that originates at the pharynx and terminates at the stomach, functions to transport food and fluids from the pharynx to the stomach via a complex, neuromuscular response to the act of swallowing. Specifically, the passage of food or fluid from the pharynx into the esophagus stimulates the peristaltic contractions designed to propel the contents forward through the esophagus. Concurrently, the lower esophageal sphincter (LES) at the gastroesophagal junction relaxes allowing the passage of esophagal contents into the stomach. Reflux of stomach contents back into the esophagus is prevented by closure of the LES. Achalasia is a disorder of unknown etiology that disrupts the normal esophageal function (3,4). In this disorder, two deficits are present. First, the normal esophagal peristaltic wave is absent. Second, the lower esophageal sphincter does not relax. The result is esophageal dilatation and severe, progressive dysphagia. Treatment for achalasia is aimed at reduction of LES pressure. This is accomplished nonsurgically via forceful balloon dilatation of the sphincter.
  • Biliary dilatation may also be performed by such balloon catheter dilatation. Biliary strictures may result from variety of processes including postoperative scarring, inflammation, or malignancy. Endoscopic balloon dilatation of these lesions has been shown to be an effective treatment approach.
  • There therefore is a need for effective devices which permit endoscopic dilatation of lesions throughout the alimentary tract. It is important that the catheters offer first-use effectiveness in an advanced design to permit rapid inflation, deflation and easy scope passage. The balloons for such devices desirably would have a long dilation length, high operating pressure, typically greater than 50 psi (3 atm, 344.7 kPa) and desirably up to 146 psi, (10 atm, 1013 kPa), low withdrawal force and high compliance. For instance, a compliance change is desirable which would allow a balloon having a 1.25-3.0 mm nominal diameter at 3 atm to grow in a generally linear manner at least 0.25 mm, preferably about 0.5 mm, or more as pressure is increased from 3 to 12 atm. For balloons about 3.25-6.0 mm nominal diameter, a growth of at least 1.0 mm over the same range would be desirable. For balloons in the range of about 6-12 mm nominal diameter, a growth of at least 2.0 mm over a 3-10 atm pressure range would be desirable. For even larger diameter balloons, for instance balloons having 3 atm diameters of 12-30 mm, a compliance curve which provides growth of about 3 mm or more, preferably about 4.0 mm or more, over the range of 3 to 9 atm is desirable.
  • In U.S. Pat. No. 5,348,538, incorporated herein by reference, there is described a single layer angioplasty balloon made of a material such as PET which follows a stepped compliance curve. The stepped compliance curves of these balloons have a low pressure segment following a first generally linear profile, a transition region, typically in the 8-14 atm range, during which the balloon rapidly expands yielding inelastically, and a higher pressure region in which the balloon expands along a generally linear, low compliance curve. The stepped compliance curve allows a physician to dilate different sized lesions without using multiple balloon catheters.
  • A polyethylene ionomer balloon with a stepped compliance curve is disclosed in EP 540 858.
  • In copending U.S. application Ser. No. 08/397,837, filed 2 Mar. 1995, entitled Block Copolymer Elastomer Catheter Balloons, incorporated herein by reference, which corresponds to WO 95/23619, there are described balloons, useful on angioplasty catheters and similar medical devices, which are made from certain block copolymer materials which provide an unusual combination of compliance, softness and strength properties.
  • Block copolymer balloons for balloon catheters, prepared using a particular heat set technique to stabilize the balloon dimensions, are also described in U.S. Pat. No. 5,500,180.
  • SUMMARY OF THE INVENTION
  • The invention provides balloons having the desired properties just described. In one aspect, the invention is a method for forming a balloon for a medical device in which a tubing of a thermoplastic polymer material is radially expanded under a first elevated pressure at a first elevated temperature to form the balloon at a first diameter, the thermoplastic polymer material being a block copolymer material and the method including the further step of annealing the balloon at a second elevated temperature less than or equal to the first temperature and a second pressure less than the first elevated pressure for a time sufficient to shrink the formed balloon to a second diameter less than the first diameter. Suitably the second temperature is in the range of 70-100° C., the second pressure is no more than about 50 psi, and the time of annealing is sufficient to shrink the balloon so that its diameter at 3 atm pressure is about 90% or less, preferably about 85% or less, of the 3 atm diameter of a correspondingly prepared balloon prepared without said shrinking step.
  • In some embodiments to improve balloon-to-balloon reproducibility of the process, the balloon may be shrunk at a very low inflation pressure (typically 0-10 psi) to a nominal diameter below that desired in the final balloon, and then pressurized at a pressure between the shrink pressure and 50 psi, at a temperature within the same range within a mold or cylinder which is sized to provide the desired nominal diameter, still below the diameter at which the balloon was initially blown, and suitably 90% or less of the initial blow diameter.
  • The shrinking process used in the invention is quite different from the heat set technique used in U.S. Pat. No. 5,500,180, in that the process of U.S. Pat. No. 5,500,180, after formation of the balloon heats the balloon under pressure of 100-500 psi to a temperature above the blowing temperature specifically for the purpose of stabilizing the balloon against shrinkage upon cooling. The present invention is directed to exploitation of shrinkage behavior in order to increase the compliance of the resulting balloon.
  • Balloons made of multiple layers of thermoplastic material, such as coextruded balloons of the types described in U.S. Pat. No. 5,195,969, U.S. Pat. No. 5,270,086, and U.S. Pat. No. 5,478,320, or separately blown dual layer balloons of the types described in U.S. Pat. No. 5,512,051, WO 96/04951 and in copending application Ser. No. 08/611,644, filed 6 Mar. 1996, all incorporated herein by reference, may also be employed in the present invention by shrinking the so-formed balloon in accordance with the present invention after it has been formed.
  • As further aspects of the invention, there are described herein balloons particularly suited to dilation of GI lesions of various types which are characterized by unique combinations of balloon diameter, high burst strength and high compliance characteristics.
  • The high strength, high compliance balloons of the invention also provide excellent rewrap characteristics, in comparison to high strength balloons formed by other processes. Consequently, after treatment of a lesion and deflation of the balloon, the force required to withdraw the balloon catheter from the body is low, especially for catheters designed to pass through endoscopes (TTS).
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a schematic side view of a through-the scope dilatation catheter of the invention.
  • FIG. 2 is a schematic side view of a dual lumen over-the wire dilatation catheter of the invention.
  • FIG. 3 is a plot showing compliance curves of balloons prepared in Examples 3 and 4.
  • FIG. 4. is a plot showing compliance curves of balloons prepared in Example 5.
  • FIG. 5. is a plot showing compliance curves of balloons prepared in Example 6.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Typically, balloon dilatation catheters for gastrointestinal applications are available in two design options: 1) through-the scope (TTS); and 2) over-the-wire (OTW). Each design offers particular advantages in specific clinical situations.
  • Referring to FIG. 1, a TTS balloon dilatation catheter 10 is shown. Catheter 10 comprises a shaft 12, a balloon 14 near the distal end thereof and an inflation apparatus 16 at the proximal end thereof. Shaft 12 has a strong flexible kink-resistant construction and includes a longitudinal lumen extending therethrough by means of which the balloon 14 may be inflated by the inflation apparatus 16. Catheter 10 is designed for direct passage through the working channel of the endoscope to the site of an obstructive lesion. Because TTS catheters are not passed over a guidewire, the design includes a mechanism for stiffening the shaft enough to allow advancement through the narrow scope channel to the lesion. To achieve this result, TTS catheters suitably incorporate a stiffening stylet 18 within the shaft. This stylet extends from the proximal end of the shaft through the length of the balloon and provides the stiffness required to facilitate passage through an endoscope and enhance appropriate positioning within the lesion.
  • TTS balloon dilatation catheters are useful when an endoscopist prefers to dilate under direct visualization. With the endoscope placed immediately proximal to the lesion, catheter advancement and balloon inflation can be directly monitored. Scope placement immediately proximal to the balloon also assists in maintaining proper balloon position during inflation. For example, during dilatation of pyloric structures, the balloon has a tendency to slip proximally or distally during inflation. By positioning the scope at the proximal end of the balloon, the endoscopist is able to mechanically block any backward movement during inflation thereby facilitating efficient, effective dilatation.
  • FIG. 2 illustrates the construction of an OTW balloon dilation catheter 30. Catheter 30 includes a shaft 32 which has a strong flexible kink-resistant construction and incorporates a double-lumen design. This design provides a lumen for guidewire passage and a lumen for balloon inflation. At the proximal end of catheter 30 the lumens of shaft 32 divide into separate portions 34, 36 which communicate respectively to balloon inflation apparatus 38 and to guidewire control apparatus 40. A balloon 42 is mounted on the shaft 32 near the distal end of catheter 30. Catheter 30 may incorporate a soft flexible tip 44 to provide less traumatic advancement through tortuous or narrow strictures. Tip 44 may be radiopaque to assist in fluoroscopic positioning of the catheter at the lesion site.
  • OTW balloon dilatation catheters are the preferred design option when extremely tortuous of difficult anatomy is encountered. In these cases, the ability to track the catheter over a previously placed guidewire enhances the clinician's ability to precisely position the balloon for effective dilatation. Further, for colonic lesions distal to scope access, a fluoroscopically-guided, OTW placement technique can be used to achieve appropriate positioning.
  • With OTW balloon dilatation catheters, the endoscopist typically monitors balloon inflation fluoroscopically rather than under direct visualization. Therefore, these dilators incorporate radiopaque markers to aid in accurate positioning. These catheters are designed to be used with guidewires and are available in a variety of shaft and balloon lengths and diameters. This allows the endoscopist to select a catheter appropriate for each lesion.
  • With regard to balloon size selection, for successful dilatation, the balloon must provide effective radial force against the entire length of the stricture. In FIGS. 1 and 2 the balloon diameter is indicated by dimension A and the dilation length indicated by dimension B. The balloon should be long enough to dilate the entire length of the stricture. The inflated outer diameter should affect the desired degree of dilatation.
  • The length of the catheter shaft required varies with the location of the stricture. For example, catheters 180 cm in length allow access to esophageal and pyloric lesions, while a catheter 240 cm in length is required for colonic strictures.
  • With the exception of Achalasia Balloon Dilators which are inflated with air, balloons are primarily inflated with water, saline or a contract/saline mixture. The latter is used with OTW balloon catheters to enhance visualization. It is important not to exceed the maximum inflation pressure specified for any particular balloon catheter. Surpassing this pressure could lead to balloon rupture.
  • During a procedure the balloon is fully inflated to the desired dilatation diameter. Dilatation force is applied for as long as necessary to achieve desired results. Using an inflation apparatus equipped with a pressure gauge, the balloons of the present invention provide a substantially wider range of stricture diameters which may be treated with a single catheter. After treatment, the deflated balloons of the invention provide substantially reduced resistance to withdrawal of the catheter from the body compared to prior art high strength balloons made for instance from biaxially oriented PET. In some TTS applications measured withdrawal force through the scope for catheters bearing balloons of the invention has been found to be only about ½ of the withdrawal force for corresponding catheters bearing PET balloons of similar burst strength.
  • For esophageal balloon dilatation TTS catheters, a balloon of approximately 8 cm length (dimension B), having an outer diameter (dimension A) of 6 to 20 mm is suitable. The preferred length of the catheter is 180 cm.
  • For pyloric balloon dilatation TTS catheters, a balloon of approximately 5.5 cm length balloon, having an outer diameter of 6 to 20 mm is suitable. The preferred length of the catheter is 180 cm.
  • For colonic balloon dilatation TTS catheters, a balloon of approximately 5.5 cm length balloon, having an outer diameter of 6 to 20 mm is suitable. The preferred length of the catheter is 240 cm.
  • For anastomotic balloon dilatation TTS catheters, a balloon of approximately 8 cm length balloon, having an outer diameter of 20-30 mm is suitable. The preferred length of the catheter is 240 cm.
  • Preferred balloon materials are block copolymers or blends of flexible and rigid thermoplastic polymers. Particularily preferred are thermoplastic block copolymers characterized as follows:
  • the block copolymer is made up of hard segments of a polyester or polyamide and soft segments of polyether;
      • the polyester hard segments are polyesters of an aromatic dicarboxylic acid and a C2-C4 diol,
      • the polyamide hard segments are polyamides of C6 or higher, preferably C10-C12, carboxylic acids and C6 or higher, preferably C10-C12, organic diamines or of C6 or higher, preferably C10-C12, aliphatic ω-amino-α-acids, and
      • the polyether soft segments are polyethers of C2-C10, preferably C4-C6 diols; and
  • the percentage by weight of the block polymer attributable to the hard segments is between about 50% and about 98%. Suitably the block copolymer has a low flexural modulus, namely less than 150,000 psi, preferably less than 120,000 psi, and has a hardness, Shore D scale, of greater than 60. From such polymers, balloons having very high compliance profiles can be prepared with high wall strength. The low flexural modulus contributes to a softer feel found with the balloons of the invention, compared to those made of other high strength polymer material.
  • The preferred balloons of the invention are made of polyamide/polyether block copolymers. The polyamide/polyether block copolymers are commonly identified by the acronym PEBA (polyether block amide). The polyamide and polyether segments of these block copolymers may be linked through amide linkages, however, most preferred are ester linked segmented polymers, i.e. polyamide/polyether polyesters. Such polyamide/polyether/polyester block copolymers are made by a molten state polycondensation reaction of a dicarboxylic polyamide and a polyether diol. The result is a short chain polyester made up of blocks of polyamide and polyether. The polyamide and polyether blocks are not miscible. Thus the materials are characterized by a two phase structure: one is a thermoplastic region that is primarily polyamide and the other is elastomer region that is rich in polyether. The polyamide segments are semicrystalline at room temperature. The generalized chemical formula for these polyester polymers may be represented by the following formula:
    Figure US20070009692A1-20070111-C00001

    in which PA is a polyamide segment, PE is a polyether segment and the repeating number n is between 5 and 10.
  • The polyamide segments are suitably aliphatic polyamides, such as nylons 12, 11, 9, 6, 6/12, 6/11, 6/9, or 6/6. Most preferably they are nylon 12 segments. The polyamide segments may also be based on aromatic polyamides but in such case significantly lower compliance characteristics are to be expected. The polyamide segments are relatively low molecular weight, generally within the range of 500-8,000, more preferably 2,000, most preferably about 3,000.
  • The polyether segments are aliphatic polyethers having at least 2 and no more than 10 linear saturated aliphatic carbon atoms between ether linkages. More preferably the ether segments have 4-6 carbons between ether linkages, and most preferably they are poly(tetramethylene ether) segments. Examples of other polyethers which may be employed in place of the preferred tetramethylene ether segments include polyethylene glycol, polypropylene glycol, poly(pentamethylene ether) and poly(hexamethylene ether). The hydrocarbon portions of the polyether may be optionally branched. An example is the polyether of 2-ethylhexane diol. Generally such branches will contain no more than two carbon atoms. The molecular weight of the polyether segments is suitably between about 400 and 2,500, preferably between 650 and 1000.
  • The weight ratio of polyamide to polyether in the polyamide/polyether polyesters used in the invention desirably should be in the range of 50/50 to 98/2, preferably between 60/30 and 92/08, more preferably, between 70/30 and 90/10.
  • Polyamide/polyether polyesters are sold commercially under the Pebax® trademark by Atochem North America, Inc., Philadelphia Pa. Examples of suitable commercially available polymers are the Pebax® 33 series polymers with hardness 60 and above, Shore D scale, especially Pebax® 7233, 7033 and 6333. These polymers are made up of nylon 12 segments and poly(tetramethylene ether) segments in different weight ratios and segment lengths.
  • It is also possible to use other PEBA polymers with the physical properties specified herein and obtain similar compliance, strength and softness characteristics in the finished balloon.
  • As an alternative to polyamide elastomers, it is also possible to utilize polyester/polyether segmented block copolymers and obtain similar balloon properties. Such polymers are made up of at least two polyester and at least two polyether segments. The polyether segments are the same as previously described for the polyamide/polyether block copolymers useful in the invention. The polyester segments are polyesters of an aromatic dicarboxylic acid and a two to four carbon diol.
  • Suitable dicarboxylic acids used to prepare the polyester segments of the polyester/polyether block copolymers are ortho-, meta- or para-phthalic acid, napthalenedicarboxylic acid or meta-terphenyl-4,4′-dicarboxylic acids.
  • Preferred polyester/polyether block copolymers are poly(butylene terephthalate)-block-poly(tetramethylene oxide) polymers such as Arnitel EM 740, sold by DSM Engineering Plastics. Hytrel polymers, sold by DuPont which meet the physical and chemical specifications set out herein can also be used.
  • It is preferred that the block copolymers have a hardness, Shore D scale, of at least 60 and a flexural modulus of no more than about 150,000, in order to obtain optimal strength, compliance and softness characteristics. Preferably the Shore D hardness is in the range of 65-75 and the flexural modulus is in the range of 50,000. The preferred polymers useful in the invention are also characterized by a high ultimate elongation of about 300% or higher and an ultimate tensile strength of at least 6,000 psi.
  • Other thermoplastic polymer materials which may be used to prepare balloons in accordance with the invention include blends of rigid and flexible polymers; polyurethanes which have flexible portions, typically derived from polyester or polyether polyols and rigid portions, typically derived from diisocyanates; random copolymers of rigid and flexible monomers; aliphatic polyketones; polysulfides such as PPS (polyphenylenesulfide); polyamides, for instance C6 or higher polyamides which are saturated with water, C11 or higher polyamide homopolymers regardless of water content, and polyamide copolymers of linear and branched monomer units; and other polymers or polymer blends which are known in the art as thermoplastic elastomers. Specific additional thermoplastic polymer products which are considered suitable include polyurethane/polycarbonate blend or block copolymers sold under the trademarks, TEXIN TPU by Bayer Corp and TECOTHANE by Thermedics Inc. and polyurethanes sold under the trademark PELLETHANE by Dow Chemical Co. As previously mentioned, multilayer balloon structures formed by concentric coextrusion of different thermoplastic polymers, or by sequential concentric blowing of separate tubing parisons of different materials, may also be employed.
  • Manufacture of balloons of the invention is started with an extruded tubing of the thermoplastic polymer material.
  • The balloon, prior to its being shrunk, may be manufactured in accordance with known techniques such as described in copending application Ser. No. 08/397,837, filed 2 Mar. 1995, entitled Block Copolymer Elastomer Catheter Balloons, incorporated herein by reference, which corresponds to WO 95/23619, and Ser. No. 08/555,219, filed 8 Nov. 1995, entitled Method of Balloon Formation by Cold Drawing/Necking, incorporated herein by reference. Multi-staged blowing techniques as described in copending application Ser. No. 08/197,639, filed 17 Feb. 1994, also incorporated herein by reference, may also be employed.
  • The balloon shrinking process is similar to that described in U.S. Pat. No. 5,348,538 for balloons of non-compliant material such as PET. However, the balloons of the invention are desirably constructed by blowing the balloon from a block copolymer or other polymer material as described above and then shrinking the balloon to a greater extent than was done in the specific illustrative examples of U.S. Pat. No. 5,348,538. The amount of shrinkage is controlled by the pressure maintained in the balloon during annealing and the temperature and time of the annealing. For a balloon made from Pebax® 7233, the blowing pressure is suitably in the range 200-400 psi, and temperature is suitably in the range of 90-100° C., and the annealing pressure is in the range of 0-50, preferably 1-30 psi at 70-100° C. for 3-30 seconds.
  • By shrinking until the balloon, at 3 atm pressure, provides a diameter of about 90% or less, preferably 85% or less, and more preferably about 65%-75% of the diameter of a correspondingly prepared balloon, at 3 atm pressure, which does not undergo shrinking, a very steep compliance curve is obtained which is more generally linear, the greater the shrinkage. Burst strength is not substantially affected by the shrinking step. However the shrinking step causes the compliance curve to start from a lower point so that overall the balloon is much more compliant. In this manner the comparatively high strength of the block copolymer material is made accessible to medical device applications where high compliance is also desirable.
  • To improve balloon-to-balloon reproducibility of the process, the balloon may be shrunk at a very low inflation pressure (typically 0-30 psi) to a nominal diameter below that desired in the final balloon, and then pressurized at a pressure between the shrink pressure and 50 psi, at a temperature within the same range within a mold or cylinder which is sized to provide the desired nominal diameter, still below the diameter at which the balloon was initially blown, and suitably 90% or less of the initial blow diameter. Example 10 is illustrative of this technique.
  • The invention is illustrated by the following non-limiting examples.
  • EXAMPLE 1(COMPARATIVE EXAMPLE)
  • Pebax® 7233 tubes with dimensions of 0.105 inch ID (inner diameter)×0.140 OD (outer diameter) are cold-drawn at a very low temperature, approximately in the range of −100° C. to −20° C. as follows. A screw driven stretching machine with a pair of pneumatic grippers is used to stretch the tubing. The center portion of the tube is cooled by directly spraying liquid N2 on the center portion. Five 50 mm length balloons are blown at 95° C. in a 16 mm diameter mold using a blowing pressure of 260 psi and a tension of 160 grams. The average double wall thickness of the balloons was 0.00282 inch. The burst pressure was 9.2 atm. The compliance from 3 atm to 5 atm was 4.2% and from 3 atm to burst pressure was 11.7%.
  • EXAMPLE 2
  • Five balloons were prepared as in Example 1. The balloons, while inflated at about 5 psi pressure, were shrunk by dipping in a 80° C. water bath for 5 minutes. The average double wall thickness after shrinking was 0.00429 inch. The average burst pressure of the balloons was 9.4 atm. The compliance from 3 atm to 5 atm was 15% and from 3 atm to burst pressure was 39%.
  • EXAMPLE 3 (COMPARATIVE EXAMPLE)
  • Pebax® 7233 tubes with dimensions of 0.0264 inch ID×0.0464 OD (outer diameter) are cold-drawn as in Example 1. A 4 mm balloon is blown at 95° C. in a mold using a blowing pressure of 450 psi and a tension of 300 grams. The burst pressure was 22 atm.
  • EXAMPLE 4
  • The process of Example 2 is repeated except that the shrinking step is performed by annealing the balloons while inflated to 2 atm pressure in water baths under different conditions, namely: 75° C. for 10 seconds; 75° C. for 30 seconds; 75° C. for 60 seconds; and 95° C. for 10 seconds. Compliance curves for the balloons of Examples 3 and 4 are plotted in FIG. 3.
  • EXAMPLE 5
  • Balloons were prepared as in Examples 1 and 2 using Pebax 7033 polymer and the conditions specified in Table 1. The compliance results are summarized in Table 1 and are plotted in FIG. 4.
  • EXAMPLE 6
  • Balloons were made from Amitel EM 740 polymer tubing by stretching tubing as specified in Table 2 at room temperature at a stretch ratio of 4.2 and then blowing the balloon from the stretched tubing under the conditions specified in Table 2. The compliance results are summarized in Table 2 and are plotted in FIG. 5.
    TABLE 1
    Mold Blowing Double
    Dia Length Tube ID × OD pressure Blowing wall Shrinking Shrinking Burst pressure Compliance 3 Compliance
    Sample (mm) (mm) (inch) (atm) tension (g) thickness temp. ° C. time\min (atm) atm-burst % %/ atm
    5A
    9 50 .0515 × .0545 400 130 .00213 none none 15 15% 1.25
    5B 9 50 .0515 × .0545 400 130 .00285 80 5 14 49% 4.45
    5C 12 50  .098 × 0.132 300 190 .00281 none none 11 15% 1.375
    5D 12 50  .098 × 0.132 300 190 .0044 81 5 11 47% 5.875
    5E 18 50 0.118 × 0.158 350 250 .00295 none none 10 11% 1.83
    5F 18 50 0.118 × 0.158 350 250 .00457 81 5 9 28% 4.66
    5G 20 80 0.135 × 0.175 300 175 .00290 none none 9  9% 1.50
    5H 20 80 0.135 × 0.175 300 175 .00413 80 1 9 27% 4.50
  • TABLE 2
    Mold Tube Blowing Burst
    Diameter Length ID × OD pressure Blowing Double wall Shrinking Shrinking pressure Compliance 3 Compliance
    (mm) (mm) (inch) (atm) tension (g) thickness temp. ° C. time\min (atm) atm-burst % %/atm
    5.5 50 .046 × .084 350 none .00275 none none 16 27% 2.00
    5.5 50 .046 × .084 350 none .00360 80 1 16 70% 5.38
  • As can be seen from FIGS. 3-5, the balloons prepared utilizing the shrinking step have very high compliance profiles, in addition to high wall strength. The shrinking step causes the compliance curve to start from a lower point so that overall the balloon is much more compliant. In this manner the comparatively high strength of the block copolymer material is made accessible to medical device applications where high compliance is also desirable.
  • EXAMPLE 9 (COMPARATIVE EXAMPLE)
  • Extruded Pebax 7233 tubes with dimensions of 0.0509 inch ID×0.0729 inch OD were prepared. Five 55 mm length balloons were blown at a temperature of 95° C. in an 8 mm diameter mold using a blowing pressure of 450 psi and a tension of 150 grams. The average double wall thickness of the balloons was 0.00174 inch. The average burst pressure was 13.6 atm. The compliance from 3 atm to 10 atm was 9.0%, and from 3 atm to burst pressure was 15%.
  • EXAMPLE 10
  • Five balloons were prepared as in Example 9. The balloons while at a tension and inflated at atmospheric pressure were shrunk by dipping in an 85° C. water bath for 2 minutes. The balloons were then each inserted into a 5.6 mm ID glass tube, replaced in the 85° bath and pressurized at 30 psi for 2 minutes. The resulting balloons had an average double wall thickness of 0.00233 inch, an average burst pressure of 12.6 mm, a compliance from 3 atm to 10 atm of 36% and a compliance from 3 atm to burst of 44%.
  • The above disclosure is intended to be illustrative and not exhaustive. These examples and description will suggest many variations and alternatives to one of ordinary skill in this art. All these alternatives and variations are intended to be included within the scope of the attached claims. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto.

Claims (22)

1-34. (canceled)
35. A balloon for a medical device made by a method wherein a tubing of a thermoplastic polymer material is radially expanded under a first elevated pressure at an elevated temperature to form the balloon at a first diameter, the thermoplastic polymer material being a block copolymer material and the method including the further step of annealing the balloon at a second elevated temperature less than the first elevated temperature and a second pressure less than the first elevated pressure for a time sufficient to shrink the formed balloon to a second diameter less than the first diameter, and wherein said annealing step occurs prior to sterilization of the medical device.
36. A balloon as in claim 35 having an operating pressure to which the balloon may be safely inflated without bursting of at least 12 atmospheres, a diameter at 3 atmospheres of from about 1.5 to about 6.0 mm and a diameter growth of at least 1.0 mm over the range of 3-12 atm.
37. A balloon as in claim 35 having an operating pressure to which the balloon may be safely inflated without bursting of at least 10 atmospheres, a diameter at 3 atmospheres of from about 6 to about 12 mm and a diameter growth of at least 2 mm over the range of 3-10 atm.
38. A balloon as in claim 35 having an operating pressure to which the balloon may be safely inflated without bursting of at least 9 atmospheres, a diameter at 3 atmospheres of from about 12 to about 30 mm and a diameter growth of at least 3 mm over the range of 3-9 atm.
39. A balloon as in claim 38 wherein said diameter growth is at least 4 mm.
40. A balloon as in claim 35 that has been sterilized subsequent to said annealing step.
41. A balloon for a medical device having a diameter at 3 atmospheres inflation pressure of at least 5 mm, a burst pressure of at least 9 atmospheres, and a growth rate in the range of 3 atmospheres to burst of at least 4% per atmosphere.
42. A balloon as in claim 41 wherein said diameter at 3 atmospheres is from about 6 to about 12 mm, the balloon further characterized by an operating pressure to which the balloon may be safely inflated without bursting of at least 10 atmospheres and a diameter growth of at least 2 mm over the range of 3-10 atmospheres.
43. A balloon as in claim 41 wherein said diameter at 3 atmospheres is at least 12 mm and said balloon has a diameter growth of at least 3 mm over the range of 3-9 atmospheres.
44. A balloon as in claim 43 wherein said diameter growth over the range of 3-9 atmospheres is at least 4 mm.
45. A balloon as in claim 43 wherein said diameter at 3 atmospheres is in the range of about 12 to about 18 mm.
46. A balloon is in claim 41 made from thermoplastic polymer material selected from the group consisting of block copolymers, thermoplastic elastomers, polymer blends, random copolymers of rigid and flexible monomers, polyurethanes which have rigid and flexible portions, polyketones, polysulfides and polyamide homopolymers and copolymers.
47. A balloon as in claim 41 formed from at least two concentric layers of different thermoplastic polymers.
48. A balloon as in claim 41 having a double wall thickness of about 0.00457 inches or less.
49. A balloon as in claim 41 wherein said diameter at 3 atmospheres is about in the range of 6-30 mm.
50. A balloon as in claim 41 wherein said diameter at 3 atmospheres is about 12 mm or more.
51. A catheter for treatment of a gastrointestional lesion comprising a balloon as in claim 41.
52. A medical device balloon formed by a method comprising:
radially expanding tubing of thermoplastic polymer material under elevated blowing pressure greater than 50 psi at an elevated blowing temperature to form the balloon to have a first diameter at 3 atm inflation pressure,
annealing the formed balloon prior to sterilization of the medical device at an elevated annealing temperature less than or equal to the blowing temperature, and at an annealing pressure which in the range of 0-20 psi, for a time sufficient to shrink the formed balloon to have a second diameter at 3 atm inflation pressure which is less than 90% of the first diameter, and then
pressurizing the balloon in a fixed diameter form, said fixed diameter being greater than said second diameter but no more than 90% of said first diameter, at a pressure above the annealing pressure but no more than 50 psi and a temperature not less than said annealing temperature and not greater than said blowing temperature for a time to provide the balloon with a final diameter at 3 atm inflation pressure which is greater than said second diameter but not more than 90% of said first diameter.
53. A medical device balloon as in claim 51 wherein said final diameter is 85% or less of said first diameter.
54. A medical device balloon as in claim 51 wherein said final diameter is 65-75% of said first diameter.
55. A medical device balloon as in claim 51 wherein the thermoplastic polymer material is a block copolymer, a thermoplastic elastomer, a polymer blend, a random copolymer of rigid and flexible monomers, polyurethanes which have rigid and flexible portions, polyketones, polysulfides or a polyamide homopolymer or copolymer.
US11/475,745 1994-03-02 2006-06-27 High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions Abandoned US20070009692A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/475,745 US20070009692A1 (en) 1994-03-02 2006-06-27 High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20455494A 1994-03-02 1994-03-02
US08/397,837 US5556383A (en) 1994-03-02 1995-03-02 Block copolymer elastomer catheter balloons
US68533896A 1996-07-23 1996-07-23
US11/009,355 US7108826B2 (en) 1994-03-02 2004-12-10 High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions
US11/475,745 US20070009692A1 (en) 1994-03-02 2006-06-27 High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/009,355 Continuation US7108826B2 (en) 1994-03-02 2004-12-10 High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions

Publications (1)

Publication Number Publication Date
US20070009692A1 true US20070009692A1 (en) 2007-01-11

Family

ID=34623673

Family Applications (2)

Application Number Title Priority Date Filing Date
US11/009,355 Expired - Fee Related US7108826B2 (en) 1994-03-02 2004-12-10 High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions
US11/475,745 Abandoned US20070009692A1 (en) 1994-03-02 2006-06-27 High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/009,355 Expired - Fee Related US7108826B2 (en) 1994-03-02 2004-12-10 High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions

Country Status (1)

Country Link
US (2) US7108826B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190344053A1 (en) * 2012-10-26 2019-11-14 Urotronic, Inc. Balloon catheters for body lumens
US20190374685A1 (en) * 2012-10-26 2019-12-12 Urotronic, Inc. Balloon catheters for body lumens
US10668188B2 (en) 2012-10-26 2020-06-02 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
US10806830B2 (en) 2012-10-26 2020-10-20 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US10881839B2 (en) 2012-10-26 2021-01-05 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US10888640B2 (en) 2015-04-24 2021-01-12 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
US11504450B2 (en) 2012-10-26 2022-11-22 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US11730864B2 (en) 2015-04-24 2023-08-22 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
US11925729B2 (en) 2022-10-17 2024-03-12 Urotronic, Inc. Drug-coated balloon catheters for body lumens

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7749585B2 (en) * 1996-10-08 2010-07-06 Alan Zamore Reduced profile medical balloon element
JP2007515973A (en) * 2003-10-17 2007-06-21 インヴァテック エス.アール.エル. Catheter balloon
US20080287984A1 (en) * 2007-05-18 2008-11-20 Jan Weber Medical balloons and methods of making the same
US9265918B2 (en) * 2008-09-03 2016-02-23 Boston Scientific Scimed, Inc. Multilayer medical balloon
US20120239076A1 (en) * 2009-11-20 2012-09-20 Cisko Jr George J Rectal stimulation device
WO2020172560A1 (en) 2019-02-22 2020-08-27 Urotronic, Inc. Drug-coated balloon catheters for body lumens
JP6664012B2 (en) 2017-05-05 2020-03-13 ウロトロニック・インコーポレイテッドUrotronic, Inc. Drug-coated balloon catheter for body cavity
CN112930208A (en) 2018-06-01 2021-06-08 恩多Rx有限责任公司 Dilation device and method of use thereof
JP2023514737A (en) 2020-02-21 2023-04-07 ジーアイイー・メディカル・インコーポレイテッド polymer-encapsulated drug particles
CA3213397A1 (en) * 2021-03-12 2022-09-15 Hope Medical Balloon catheter methods of use

Citations (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154244A (en) * 1977-11-21 1979-05-15 Baxter Travenol Laboratories, Inc. Balloon-type catheter
US4254774A (en) * 1979-02-14 1981-03-10 The United States Of America As Represented By The Department Of Health, Education And Welfare Balloon catheter and technique for the manufacture thereof
US4275180A (en) * 1977-04-12 1981-06-23 Raychem Limited Polymer compositions
US4331786A (en) * 1979-10-02 1982-05-25 Ato Chimie Moldable and/or extrudable polyether-ester-amide block copolymers
US4332920A (en) * 1974-05-31 1982-06-01 Ato Chimie Mouldable and extrudable polyether-ester-amide block copolymers
US4385635A (en) * 1980-04-25 1983-05-31 Ruiz Oscar F Angiographic catheter with soft tip end
US4413989A (en) * 1980-09-08 1983-11-08 Angiomedics Corporation Expandable occlusion apparatus
US4467002A (en) * 1981-12-15 1984-08-21 Raychem Limited Dimensionally-recoverable article
US4490421A (en) * 1983-07-05 1984-12-25 E. I. Du Pont De Nemours And Company Balloon and manufacture thereof
US4563181A (en) * 1983-02-18 1986-01-07 Mallinckrodt, Inc. Fused flexible tip catheter
US4587075A (en) * 1983-04-22 1986-05-06 Metal Box P.L.C. Method and apparatus for making dimensionally stable thermoplastic tubular articles
US4675361A (en) * 1980-02-29 1987-06-23 Thoratec Laboratories Corp. Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming
US4711624A (en) * 1985-03-18 1987-12-08 Metal Box P.L.C. Apparatus for heat-setting a tubular article of crystallizable polymer
US4786556A (en) * 1986-03-24 1988-11-22 Becton, Dickinson And Company Polymeric articles having enhanced antithrombogenic activity
US4822361A (en) * 1985-12-24 1989-04-18 Sumitomo Electric Industries, Ltd. Tubular prosthesis having a composite structure
US4886506A (en) * 1986-12-23 1989-12-12 Baxter Travenol Laboratories, Inc. Soft tip catheter
US4898591A (en) * 1988-08-09 1990-02-06 Mallinckrodt, Inc. Nylon-PEBA copolymer catheter
US4906244A (en) * 1988-10-04 1990-03-06 Cordis Corporation Balloons for medical devices and fabrication thereof
US4917667A (en) * 1988-02-11 1990-04-17 Retroperfusion Systems, Inc. Retroperfusion balloon catheter and method
US4938676A (en) * 1988-10-04 1990-07-03 Cordis Corporation Apparatus for manufacturing balloons for medical devices
US4950239A (en) * 1988-08-09 1990-08-21 Worldwide Medical Plastics Inc. Angioplasty balloons and balloon catheters
US4950257A (en) * 1988-09-15 1990-08-21 Mallinckrodt, Inc. Catheter introducer with flexible tip
US4952357A (en) * 1988-08-08 1990-08-28 Scimed Life Systems, Inc. Method of making a polyimide balloon catheter
US5092839A (en) * 1989-09-29 1992-03-03 Kipperman Robert M Coronary thrombectomy
US5167239A (en) * 1991-05-30 1992-12-01 Endomedix Corporation Anchorable guidewire
US5250069A (en) * 1987-02-27 1993-10-05 Terumo Kabushiki Kaisha Catheter equipped with expansible member and production method thereof
US5264260A (en) * 1991-06-20 1993-11-23 Saab Mark A Dilatation balloon fabricated from low molecular weight polymers
US5281677A (en) * 1992-09-03 1994-01-25 Becton, Dickinson And Company Thermoplastic polyurethane blends
US5290306A (en) * 1989-11-29 1994-03-01 Cordis Corporation Puncture resistant balloon catheter
US5295978A (en) * 1990-12-28 1994-03-22 Union Carbide Chemicals & Plastics Technology Corporation Biocompatible hydrophilic complexes and process for preparation and use
US5300048A (en) * 1993-05-12 1994-04-05 Sabin Corporation Flexible, highly radiopaque plastic material catheter
US5304340A (en) * 1991-09-06 1994-04-19 C. R. Bard, Inc. Method of increasing the tensile strength of a dilatation balloon
US5304134A (en) * 1992-01-17 1994-04-19 Danforth Biomedical, Inc. Lubricious yet bondable catheter channel sleeve for over-the-wire catheters
US5328468A (en) * 1991-10-08 1994-07-12 Terumo Kabushiki Kaisha Balloon for blood vessel-dilating catheter
US5335675A (en) * 1988-11-15 1994-08-09 Family Health International Stress-softened elastomeric films, articles, and method and apparatus for making such films and articles
US5344400A (en) * 1992-04-06 1994-09-06 Terumo Kabushiki Kaisha Balloon catheters containing molded polyarylenesulfide material
US5348538A (en) * 1992-09-29 1994-09-20 Scimed Life Systems, Inc. Shrinking balloon catheter having nonlinear or hybrid compliance curve
US5358486A (en) * 1987-01-09 1994-10-25 C. R. Bard, Inc. Multiple layer high strength balloon for dilatation catheter
US5397306A (en) * 1989-12-20 1995-03-14 Terumo Kabushiki Kaisha Catheter
US5500180A (en) * 1992-09-30 1996-03-19 C. R. Bard, Inc. Method of making a distensible dilatation balloon using a block copolymer
US5533968A (en) * 1991-05-15 1996-07-09 Advanced Cardiovascular Systems, Inc. Low profile catheter with expandable outer tubular member
US5556383A (en) * 1994-03-02 1996-09-17 Scimed Lifesystems, Inc. Block copolymer elastomer catheter balloons
US5628755A (en) * 1995-02-20 1997-05-13 Schneider (Europe) A.G. Balloon catheter and stent delivery system
US5714110A (en) * 1993-09-20 1998-02-03 Scimed Life Systems, Inc. Process improvements for preparing catheter balloons
US5749851A (en) * 1995-03-02 1998-05-12 Scimed Life Systems, Inc. Stent installation method using balloon catheter having stepped compliance curve
US5772641A (en) * 1995-12-12 1998-06-30 Medi-Dyne Inc. Overlapping welds for catheter constructions
US5797877A (en) * 1993-10-01 1998-08-25 Boston Scientific Corporation Medical device balloons containing thermoplastic elastomers
US5833657A (en) * 1995-05-30 1998-11-10 Ethicon, Inc. Single-walled balloon catheter with non-linear compliance characteristic
US6946174B1 (en) * 2000-10-12 2005-09-20 Boston Scientific Scimed, Inc. Moisture curable balloon materials
US7465483B2 (en) * 1994-06-27 2008-12-16 C.R.Bard Inc. Radially expandable polytetrafluoroethylene
US7749585B2 (en) * 1996-10-08 2010-07-06 Alan Zamore Reduced profile medical balloon element

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984001513A1 (en) 1982-10-08 1984-04-26 David Hardcastle Balloon catheter and process for the manufacture thereof
EP0274411A3 (en) 1987-01-09 1988-11-30 C.R. Bard, Inc. Thin wall high strength balloon and method of manufacture
FR2651681B1 (en) 1989-09-11 1991-12-13 Medicorp Research Lab CATHETER.
ATE91638T1 (en) 1989-09-25 1993-08-15 Schneider Usa Inc MULTI-LAYER EXTRUSION AS A PROCESS FOR MANUFACTURING BALLOONS FOR VESSEL PLASTIC.
US5478320A (en) * 1989-11-29 1995-12-26 Cordis Corporation Puncture resistant balloon catheter and method of manufacturing
EP0974370B1 (en) 1990-11-09 2006-04-19 Boston Scientific Corporation Balloon for medical catheter
JP2555298B2 (en) 1990-11-10 1996-11-20 テルモ株式会社 CATHETER BALLOON, CATHETER BALLOON MANUFACTURING METHOD, AND BALLOON CATHETER
US5195969A (en) 1991-04-26 1993-03-23 Boston Scientific Corporation Co-extruded medical balloons and catheter using such balloons
AU634060B2 (en) 1991-05-16 1993-02-11 Terumo Kabushiki Kaisha Indwelling catheter
US5199989A (en) * 1991-07-31 1993-04-06 Ransburg Corporation Powder booth floor wiping mechanism
EP0972535B1 (en) 1991-09-12 2005-12-28 Advanced Cardiovascular Systems, Inc. Inflatable member having elastic expansion with limited range
EP0566755B1 (en) 1992-04-21 1996-06-19 Cordis Corporation Polyetheramide tubing for medical devices
US5378468A (en) * 1992-09-22 1995-01-03 The Mennen Company Composition containing body activated fragrance for contacting the skin and method of use
US5512051A (en) * 1993-02-16 1996-04-30 Boston Scientific Corporation Slip-layered catheter balloon
US5587125A (en) 1994-08-15 1996-12-24 Schneider (Usa) Inc. Non-coextrusion method of making multi-layer angioplasty balloons
WO1996012516A1 (en) 1994-10-19 1996-05-02 Advanced Cardiovascular Systems, Inc. High strength dilatation balloons
US6797877B1 (en) * 2003-04-28 2004-09-28 Jonn Maneely Company Electrical metallic tube, coupling, and connector apparatus and method

Patent Citations (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4332920A (en) * 1974-05-31 1982-06-01 Ato Chimie Mouldable and extrudable polyether-ester-amide block copolymers
US4275180A (en) * 1977-04-12 1981-06-23 Raychem Limited Polymer compositions
US4154244A (en) * 1977-11-21 1979-05-15 Baxter Travenol Laboratories, Inc. Balloon-type catheter
US4254774A (en) * 1979-02-14 1981-03-10 The United States Of America As Represented By The Department Of Health, Education And Welfare Balloon catheter and technique for the manufacture thereof
US4331786A (en) * 1979-10-02 1982-05-25 Ato Chimie Moldable and/or extrudable polyether-ester-amide block copolymers
US4675361A (en) * 1980-02-29 1987-06-23 Thoratec Laboratories Corp. Polymer systems suitable for blood-contacting surfaces of a biomedical device, and methods for forming
US4385635A (en) * 1980-04-25 1983-05-31 Ruiz Oscar F Angiographic catheter with soft tip end
US4413989A (en) * 1980-09-08 1983-11-08 Angiomedics Corporation Expandable occlusion apparatus
US4467002A (en) * 1981-12-15 1984-08-21 Raychem Limited Dimensionally-recoverable article
US4563181A (en) * 1983-02-18 1986-01-07 Mallinckrodt, Inc. Fused flexible tip catheter
US4587075A (en) * 1983-04-22 1986-05-06 Metal Box P.L.C. Method and apparatus for making dimensionally stable thermoplastic tubular articles
US4490421A (en) * 1983-07-05 1984-12-25 E. I. Du Pont De Nemours And Company Balloon and manufacture thereof
US4711624A (en) * 1985-03-18 1987-12-08 Metal Box P.L.C. Apparatus for heat-setting a tubular article of crystallizable polymer
US4822361A (en) * 1985-12-24 1989-04-18 Sumitomo Electric Industries, Ltd. Tubular prosthesis having a composite structure
US4786556A (en) * 1986-03-24 1988-11-22 Becton, Dickinson And Company Polymeric articles having enhanced antithrombogenic activity
US4886506A (en) * 1986-12-23 1989-12-12 Baxter Travenol Laboratories, Inc. Soft tip catheter
US5358486A (en) * 1987-01-09 1994-10-25 C. R. Bard, Inc. Multiple layer high strength balloon for dilatation catheter
US5250069A (en) * 1987-02-27 1993-10-05 Terumo Kabushiki Kaisha Catheter equipped with expansible member and production method thereof
US4917667A (en) * 1988-02-11 1990-04-17 Retroperfusion Systems, Inc. Retroperfusion balloon catheter and method
US4952357A (en) * 1988-08-08 1990-08-28 Scimed Life Systems, Inc. Method of making a polyimide balloon catheter
US4950239A (en) * 1988-08-09 1990-08-21 Worldwide Medical Plastics Inc. Angioplasty balloons and balloon catheters
US4898591A (en) * 1988-08-09 1990-02-06 Mallinckrodt, Inc. Nylon-PEBA copolymer catheter
US4950257A (en) * 1988-09-15 1990-08-21 Mallinckrodt, Inc. Catheter introducer with flexible tip
US4938676A (en) * 1988-10-04 1990-07-03 Cordis Corporation Apparatus for manufacturing balloons for medical devices
US4906244A (en) * 1988-10-04 1990-03-06 Cordis Corporation Balloons for medical devices and fabrication thereof
US5335675A (en) * 1988-11-15 1994-08-09 Family Health International Stress-softened elastomeric films, articles, and method and apparatus for making such films and articles
US5092839A (en) * 1989-09-29 1992-03-03 Kipperman Robert M Coronary thrombectomy
US5290306A (en) * 1989-11-29 1994-03-01 Cordis Corporation Puncture resistant balloon catheter
US5397306A (en) * 1989-12-20 1995-03-14 Terumo Kabushiki Kaisha Catheter
US5295978A (en) * 1990-12-28 1994-03-22 Union Carbide Chemicals & Plastics Technology Corporation Biocompatible hydrophilic complexes and process for preparation and use
US5533968A (en) * 1991-05-15 1996-07-09 Advanced Cardiovascular Systems, Inc. Low profile catheter with expandable outer tubular member
US5167239A (en) * 1991-05-30 1992-12-01 Endomedix Corporation Anchorable guidewire
US5264260A (en) * 1991-06-20 1993-11-23 Saab Mark A Dilatation balloon fabricated from low molecular weight polymers
US5304340A (en) * 1991-09-06 1994-04-19 C. R. Bard, Inc. Method of increasing the tensile strength of a dilatation balloon
US5328468A (en) * 1991-10-08 1994-07-12 Terumo Kabushiki Kaisha Balloon for blood vessel-dilating catheter
US5304134A (en) * 1992-01-17 1994-04-19 Danforth Biomedical, Inc. Lubricious yet bondable catheter channel sleeve for over-the-wire catheters
US5344400A (en) * 1992-04-06 1994-09-06 Terumo Kabushiki Kaisha Balloon catheters containing molded polyarylenesulfide material
US5281677A (en) * 1992-09-03 1994-01-25 Becton, Dickinson And Company Thermoplastic polyurethane blends
US5348538A (en) * 1992-09-29 1994-09-20 Scimed Life Systems, Inc. Shrinking balloon catheter having nonlinear or hybrid compliance curve
US5500180A (en) * 1992-09-30 1996-03-19 C. R. Bard, Inc. Method of making a distensible dilatation balloon using a block copolymer
US5300048A (en) * 1993-05-12 1994-04-05 Sabin Corporation Flexible, highly radiopaque plastic material catheter
US5714110A (en) * 1993-09-20 1998-02-03 Scimed Life Systems, Inc. Process improvements for preparing catheter balloons
US5797877A (en) * 1993-10-01 1998-08-25 Boston Scientific Corporation Medical device balloons containing thermoplastic elastomers
US5556383A (en) * 1994-03-02 1996-09-17 Scimed Lifesystems, Inc. Block copolymer elastomer catheter balloons
US7465483B2 (en) * 1994-06-27 2008-12-16 C.R.Bard Inc. Radially expandable polytetrafluoroethylene
US5628755A (en) * 1995-02-20 1997-05-13 Schneider (Europe) A.G. Balloon catheter and stent delivery system
US20020183780A1 (en) * 1995-03-02 2002-12-05 Lixiao Wang Stent installation method using balloon catheter having stepped compliance curve
US5980532A (en) * 1995-03-02 1999-11-09 Scimed Life Systems, Inc. Stent installation method using balloon catheter having stepped compliance curve
US6290485B1 (en) * 1995-03-02 2001-09-18 Lixiao Wang Mold for forming a balloon catheter having stepped compliance curve
US6402778B2 (en) * 1995-03-02 2002-06-11 Scimed Life Systems, Inc. Stent installation method using balloon catheter having stepped compliance curve
US5749851A (en) * 1995-03-02 1998-05-12 Scimed Life Systems, Inc. Stent installation method using balloon catheter having stepped compliance curve
US5833657A (en) * 1995-05-30 1998-11-10 Ethicon, Inc. Single-walled balloon catheter with non-linear compliance characteristic
US5772641A (en) * 1995-12-12 1998-06-30 Medi-Dyne Inc. Overlapping welds for catheter constructions
US7749585B2 (en) * 1996-10-08 2010-07-06 Alan Zamore Reduced profile medical balloon element
US6946174B1 (en) * 2000-10-12 2005-09-20 Boston Scientific Scimed, Inc. Moisture curable balloon materials

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11439801B2 (en) * 2012-10-26 2022-09-13 Urotronic, Inc. Balloon catheters for body lumens
US11826532B2 (en) 2012-10-26 2023-11-28 Urotronic, Inc. Balloon catheters for body lumens
US10668188B2 (en) 2012-10-26 2020-06-02 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
US10675386B2 (en) 2012-10-26 2020-06-09 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
US10806830B2 (en) 2012-10-26 2020-10-20 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US10850076B2 (en) * 2012-10-26 2020-12-01 Urotronic, Inc. Balloon catheters for body lumens
US10881839B2 (en) 2012-10-26 2021-01-05 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US10994103B2 (en) 2012-10-26 2021-05-04 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US10898700B2 (en) * 2012-10-26 2021-01-26 Urotronic, Inc. Balloon catheters for body lumens
US10987451B2 (en) 2012-10-26 2021-04-27 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US10994104B2 (en) 2012-10-26 2021-05-04 Urotronic, Inc. Balloon catheters for body lumens
US20190374685A1 (en) * 2012-10-26 2019-12-12 Urotronic, Inc. Balloon catheters for body lumens
US11471655B2 (en) 2012-10-26 2022-10-18 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US11471656B2 (en) 2012-10-26 2022-10-18 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US20190344053A1 (en) * 2012-10-26 2019-11-14 Urotronic, Inc. Balloon catheters for body lumens
US11826533B2 (en) 2012-10-26 2023-11-28 Urotronic, Inc. Balloon catheters for body lumens
US11504450B2 (en) 2012-10-26 2022-11-22 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US11648338B2 (en) 2012-10-26 2023-05-16 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US11648337B2 (en) 2012-10-26 2023-05-16 Urotronic, Inc. Drug-coated balloon catheters for body lumens
US11730864B2 (en) 2015-04-24 2023-08-22 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
US11484628B2 (en) 2015-04-24 2022-11-01 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
US11904072B2 (en) 2015-04-24 2024-02-20 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
US10888640B2 (en) 2015-04-24 2021-01-12 Urotronic, Inc. Drug coated balloon catheters for nonvascular strictures
US11925729B2 (en) 2022-10-17 2024-03-12 Urotronic, Inc. Drug-coated balloon catheters for body lumens

Also Published As

Publication number Publication date
US20050119683A1 (en) 2005-06-02
US7108826B2 (en) 2006-09-19

Similar Documents

Publication Publication Date Title
EP0921832B1 (en) Method for forming high compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions
US20070009692A1 (en) High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions
WO1998003218A9 (en) High compliance, high strength catheter balloons useful for treatment of gastrointestinal lesions
US11357892B2 (en) Multilayer medical balloon
US20020018866A1 (en) Polyether block amide catheter balloons
EP0888145B1 (en) Process for forming a laminate catheter balloon
US9669196B2 (en) Robust multi-layer balloon
EP2361103B1 (en) Low compliant catheter tubing
US20150105815A1 (en) High pressure tear resistant balloon
US20090264822A1 (en) Method of Making a Zero-Fold Balloon With Variable Inflation Volume
US20090254113A1 (en) Dilatation balloon with ridges and methods
JP4815657B2 (en) Medical polymer blend material and medical balloon using this material
JP4402218B2 (en) Balloon catheter

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION